Literature DB >> 9312114

Oncogenic raf-1 induces the expression of non-histone chromosomal architectural protein HMGI-C via a p44/p42 mitogen-activated protein kinase-dependent pathway in salivary epithelial cells.

D Li1, H H Lin, M McMahon, H Ma, D K Ann.   

Abstract

The enzyme activity of mitogen-activated protein kinase (MAP kinase) increases in response to agents acting on a variety of cell surface receptors, including receptors linked to heterotrimeric G proteins. In this report, we demonstrated that Raf-1 protein kinase activity in the mouse parotid glands was induced by chronic isoproterenol administration in whole animals. To investigate the molecular nature underlying cellular responses to Raf-1 activation, we have stably transfected rat salivary epithelial Pa-4 cells with human Raf-1-estrogen receptor fusion gene (DeltaRaf-1:ER) and used mRNA differential display in search of messages induced by DeltaRaf-1:ER activation. Through this approach, the gene encoding non-histone chromosomal protein HMGI-C was identified as one of the target genes activated by oncogenic Raf-1 kinase. Activation of Raf-1 kinase resulted in a delayed and sustained increase of HMGI-C expression in the Pa-4 cells. The induction of HMGI-C mRNA level is sensitive to both the protein synthesis inhibitor cycloheximide and transcription inhibitor actinomycin D. The role of the extracellular signal-related kinase (ERK) signaling pathway in the HMGI-C induction was highlighted by the result that the MAP kinase kinase (MEK) inhibitor, PD 98059, blocked DeltaRaf-1:ER- and 12-O-tetradecanoylphorbol-13-acetate-stimulated HMGI-C induction. Altogether, these findings support the notion that the Raf/MEK/ERK signaling module, at least in part, regulates transcriptional activation of the chromosomal architectural protein HMGI-C.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9312114     DOI: 10.1074/jbc.272.40.25062

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Multifunctional aptamer-miRNA conjugates for targeted cancer therapy.

Authors:  Carla L Esposito; Laura Cerchia; Silvia Catuogno; Gennaro De Vita; Justin P Dassie; Gianluca Santamaria; Piotr Swiderski; Gerolama Condorelli; Paloma H Giangrande; Vittorio de Franciscis
Journal:  Mol Ther       Date:  2014-01-20       Impact factor: 11.454

2.  Expression profiling of uterine leiomyomata cytogenetic subgroups reveals distinct signatures in matched myometrium: transcriptional profilingof the t(12;14) and evidence in support of predisposing genetic heterogeneity.

Authors:  Jennelle C Hodge; Tae-Min Kim; Jonathan M Dreyfuss; Priya Somasundaram; Nicole C Christacos; Marissa Rousselle; Bradley J Quade; Peter J Park; Elizabeth A Stewart; Cynthia C Morton
Journal:  Hum Mol Genet       Date:  2012-02-17       Impact factor: 6.150

Review 3.  The HMG I proteins: dynamic roles in gene activation, development, and tumorigenesis.

Authors:  F Liu; K Y Chau; P Arlotta; S J Ono
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

4.  Three-dimensional collagen I promotes gemcitabine resistance in pancreatic cancer through MT1-MMP-mediated expression of HMGA2.

Authors:  Surabhi Dangi-Garimella; Seth B Krantz; Morgan R Barron; Mario A Shields; Michael J Heiferman; Paul J Grippo; David J Bentrem; Hidayatullah G Munshi
Journal:  Cancer Res       Date:  2010-12-08       Impact factor: 12.701

5.  SUMOylation attenuates sensitivity toward hypoxia- or desferroxamine-induced injury by modulating adaptive responses in salivary epithelial cells.

Authors:  Ha-Van Nguyen; Jo-Lin Chen; Jenny Zhong; Kwang-Jin Kim; Edward D Crandall; Zea Borok; Yuan Chen; David K Ann
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

6.  Gene expressions of HMGI-C and HMGI(Y) are associated with stage and metastasis in colorectal cancer.

Authors:  Meng-Lin Huang; Chou-Chan Chen; Li-Ching Chang
Journal:  Int J Colorectal Dis       Date:  2009-07-17       Impact factor: 2.571

7.  Extra-cellular signal-regulated ERK-1/ERK-2 pathway activation in human salivary gland mucoepidermoid carcinoma: association to aggressive tumor behavior and tumor cell proliferation.

Authors:  Adriana Handra-Luca; Hadi Bilal; Jacques-Charles Bertrand; Pierre Fouret
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

8.  SUMOylation of HMGA2: selective destabilization of promyelocytic leukemia protein via proteasome.

Authors:  Xuefei Cao; Carlos Clavijo; Xu Li; H Helen Lin; Yuan Chen; Hsiu-Ming Shih; David K Ann
Journal:  Mol Cancer Ther       Date:  2008-04       Impact factor: 6.261

9.  RAF1-MEK1-ERK/AKT axis may confer NSCLC cell lines resistance to erlotinib.

Authors:  Zhi-Hong Xu; Jun-Biao Hang; Jia-An Hu; Bei-Li Gao
Journal:  Int J Clin Exp Pathol       Date:  2013-07-15

10.  Epithelial-mesenchymal-transition-like and TGFβ pathways associated with autochthonous inflammatory melanoma development in mice.

Authors:  Maria Wehbe; Saïdi M Soudja; Amandine Mas; Lionel Chasson; Rodolphe Guinamard; Céline Powis de Tenbossche; Grégory Verdeil; Benoît Van den Eynde; Anne-Marie Schmitt-Verhulst
Journal:  PLoS One       Date:  2012-11-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.